474 related articles for article (PubMed ID: 21977033)
1. Tumor angiogenesis as a target for dietary cancer prevention.
Li WW; Li VW; Hutnik M; Chiou AS
J Oncol; 2012; 2012():879623. PubMed ID: 21977033
[TBL] [Abstract][Full Text] [Related]
2. Remembering Judah Moses Folkma.
Gasparini G
Int J Biol Markers; 2008; 23(1):63. PubMed ID: 28207107
[TBL] [Abstract][Full Text] [Related]
3. Future prospects and challenges of antiangiogenic cancer gene therapy.
Samaranayake H; Määttä AM; Pikkarainen J; Ylä-Herttuala S
Hum Gene Ther; 2010 Apr; 21(4):381-96. PubMed ID: 20163246
[TBL] [Abstract][Full Text] [Related]
4. The Minderoo-Monaco Commission on Plastics and Human Health.
Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations?
Sessa C; Guibal A; Del Conte G; Rüegg C
Nat Clin Pract Oncol; 2008 Jul; 5(7):378-91. PubMed ID: 18560389
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenesis therapy: an update after the first decade.
De Falco S
Korean J Intern Med; 2014 Jan; 29(1):1-11. PubMed ID: 24574826
[TBL] [Abstract][Full Text] [Related]
8. Tumor angiogenesis revisited: Regulators and clinical implications.
Ronca R; Benkheil M; Mitola S; Struyf S; Liekens S
Med Res Rev; 2017 Nov; 37(6):1231-1274. PubMed ID: 28643862
[TBL] [Abstract][Full Text] [Related]
9. Endostatin: the logic of antiangiogenic therapy.
Abdollahi A; Hlatky L; Huber PE
Drug Resist Updat; 2005; 8(1-2):59-74. PubMed ID: 15939343
[TBL] [Abstract][Full Text] [Related]
10. Beyond anti-VEGF: dual-targeting antiangiogenic and antiproliferative therapy.
Chen CT; Hung MC
Am J Transl Res; 2013; 5(4):393-403. PubMed ID: 23724163
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic therapy for cancer: an update.
Al-Husein B; Abdalla M; Trepte M; Deremer DL; Somanath PR
Pharmacotherapy; 2012 Dec; 32(12):1095-111. PubMed ID: 23208836
[TBL] [Abstract][Full Text] [Related]
12. Markers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where Are We Now and What Should Be Next?
Cidon EU; Alonso P; Masters B
Clin Med Insights Oncol; 2016; 10(Suppl 1):41-55. PubMed ID: 27147901
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenesis: the fifth cancer treatment modality?
Camp-Sorrell D
Oncol Nurs Forum; 2003; 30(6):934-44. PubMed ID: 14603351
[TBL] [Abstract][Full Text] [Related]
14. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
15. The discovery of antiangiogenic molecules: a historical review.
Ribatti D
Curr Pharm Des; 2009; 15(4):345-52. PubMed ID: 19199962
[TBL] [Abstract][Full Text] [Related]
16. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
17. Forty-year journey of angiogenesis translational research.
Cao Y; Arbiser J; D'Amato RJ; D'Amore PA; Ingber DE; Kerbel R; Klagsbrun M; Lim S; Moses MA; Zetter B; Dvorak H; Langer R
Sci Transl Med; 2011 Dec; 3(114):114rv3. PubMed ID: 22190240
[TBL] [Abstract][Full Text] [Related]
18. New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer.
Qiang H; Chang Q; Xu J; Qian J; Zhang Y; Lei Y; Han B; Chu T
J Cancer Res Clin Oncol; 2020 Mar; 146(3):631-645. PubMed ID: 32065262
[TBL] [Abstract][Full Text] [Related]
19. Novel therapeutic approaches targeting vascular endothelial growth factor and its receptors in haematological malignancies.
Ribatti D; Vacca A
Curr Cancer Drug Targets; 2005 Dec; 5(8):573-8. PubMed ID: 16375663
[TBL] [Abstract][Full Text] [Related]
20. The Angiopoietin-2 and TIE Pathway as a Therapeutic Target for Enhancing Antiangiogenic Therapy and Immunotherapy in Patients with Advanced Cancer.
Leong A; Kim M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33217955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
